These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3160313

  • 1. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.
    Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ.
    Ann Surg; 1985 Aug; 202(2):176-81. PubMed ID: 3160313
    [Abstract] [Full Text] [Related]

  • 2. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001 Aug; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

  • 3. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ.
    Cancer; 1986 Feb 01; 57(3):465-70. PubMed ID: 2935242
    [Abstract] [Full Text] [Related]

  • 4. [Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine].
    Bergmann JF, Rougier P, Liguory C, Zafrani ES, Métreau JM, Dhumeaux D.
    Gastroenterol Clin Biol; 1986 Feb 01; 10(2):177-9. PubMed ID: 2939001
    [Abstract] [Full Text] [Related]

  • 5. Sclerosing cholangitis from intraarterial floxuridine.
    Dikengil A, Siskind BN, Morse SS, Swedlund A, Bober-Sorcinelli KE, Burrell MI.
    J Clin Gastroenterol; 1986 Dec 01; 8(6):690-3. PubMed ID: 2949003
    [Abstract] [Full Text] [Related]

  • 6. Biliary sclerosis associated with hepatic artery infusion of floxuridine.
    Bolton JS, Bowen JC.
    Surgery; 1986 Jan 01; 99(1):119-22. PubMed ID: 2934836
    [Abstract] [Full Text] [Related]

  • 7. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries.
    Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, Doroshow J, Ganteaume L, Hill RL, Kokal WA, Riihimaki DU.
    Cancer; 1986 Feb 01; 57(3):492-8. PubMed ID: 2935243
    [Abstract] [Full Text] [Related]

  • 8. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
    Hohn D, Melnick J, Stagg R, Altman D, Friedman M, Ignoffo R, Ferrell L, Lewis B.
    J Clin Oncol; 1985 Jan 01; 3(1):98-102. PubMed ID: 3155548
    [Abstract] [Full Text] [Related]

  • 9. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ, Boddie AW, Charnsangavej C, Ajani JA, Wallace S, Soski M, Claghorn L, Mavligit GM.
    J Clin Oncol; 1986 Sep 01; 4(9):1356-64. PubMed ID: 2943876
    [Abstract] [Full Text] [Related]

  • 10. Endoscopic biliary stent placement for bile duct stricture after hepatic artery infusion of 5-FUDR.
    Siegel JH, Ramsey WH.
    J Clin Gastroenterol; 1986 Dec 01; 8(6):673-6. PubMed ID: 2949002
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 01; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 12. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.
    Weiss GR, Garnick MB, Osteen RT, Steele GD, Wilson RE, Schade D, Kaplan WD, Boxt LM, Kandarpa K, Mayer RJ.
    J Clin Oncol; 1983 May 01; 1(5):337-44. PubMed ID: 6199474
    [Abstract] [Full Text] [Related]

  • 13. Floxuridine-associated sclerosing cholangitis. A dog model.
    Andrews JC, Knol J, Wollner I, Knutsen C, Smith P, Prieskorn D, Ensminger W.
    Invest Radiol; 1989 Jan 01; 24(1):47-51. PubMed ID: 2521845
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
    Sigurdson ER, Ridge JA, Daly JM.
    Surgery; 1986 Aug 01; 100(2):285-91. PubMed ID: 2943036
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
    Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM.
    Ann Surg; 1987 Dec 01; 206(6):685-93. PubMed ID: 2961314
    [Abstract] [Full Text] [Related]

  • 18. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M, Müller HH.
    J Clin Oncol; 2000 Jan 01; 18(2):243-54. PubMed ID: 10637236
    [Abstract] [Full Text] [Related]

  • 19. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P.
    J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279
    [Abstract] [Full Text] [Related]

  • 20. [Sclerosing cholangitis-induced biliary cyst formation: complication of hepatic artery infusion chemotherapy].
    Miyamoto S, Umekita N, Maeshiro T, Awane Y.
    Gan To Kagaku Ryoho; 1995 Sep 01; 22(11):1684-6. PubMed ID: 7574792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.